We are live on ! Find out more
UL

Ulys LLC Portfolio holdings

AUM $25.4M
1-Year Est. Return 201.03%
This Fund
S&P 500
This Quarter Est. Return
-10.22%
1 Year Est. Return
+201.03%
3 Year Est. Return
-31.51%
5 Year Est. Return
-50.88%
10 Year Est. Return
AUM
$51.6M
AUM Growth
-$5.88M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXRX icon
1
Lexicon Pharmaceuticals
LXRX
$1.04B
$51.6M 100%
4,321,214
CERE
2
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$1K ﹤0.01%
3,891

Similar funds

Ulys LLC's Q1 2016 Portfolio in Review

As of Q1 2016, Ulys LLC held 2 positions worth $51.6M, down 10% from $57.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 0%. Ulys LLC opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier.

  • Ulys LLC's ten largest holdings make up 100% of its $51.6M portfolio in Q1 2016.
  • Ulys LLC opened 0 new positions and closed 0 in Q1 2016.
  • Ulys LLC's portfolio value fell 10% quarter-over-quarter to $51.6M.

Based on Ulys LLC's 13F filing for Q1 2016, filed 12 May 2016.